Mv. Medvedeva et al., INFLUENCE OF THE ANTIDEPRESSANT PYRAZIDOLE AND ITS NITRO ANALOG ON CGMP-DEPENDENT PHOSPHODIESTERASE FROM THE SOLUBLE FRACTION OF HUMAN BRAIN CORTEX, Biochemistry, 58(5), 1993, pp. 523-531
The influence of the antidepressant drug pyrazidole (pirlindole) and i
ts nitro analog on cGMP-dependent phosphodiesterase from the soluble f
raction of human brain cortex has been studied. Pyrazidole inhibits th
e cGMP-induced activity of phosphodiesterase (IC50 = 1585 muM) without
influencing the basal activity; its action is noncompetitive. with re
spect to the substrate and the activator. Nitropyrazidole is a more po
tent inhibitor of cGMP-dependent phosphodiesterase (IC50 = 115 muM), c
ompeting with the substrate for the catalytic site (K(i) = 70 muM). Th
ere is no direct interaction of pyrazidole or its nitro analog and the
cGMP-specific allosteric site of the phosphodiesterase.